Society of Gynecologic Oncology Journal Club: Controversial conversations in gynecologic cancer – The ABCs of ADCs (antibody drug conjugates) Editorial

   


Authors: Martin, J.; Zacholski, E.; O'Cearbhaill, R.; Matulonis, U.; Chen, L.
Title: Society of Gynecologic Oncology Journal Club: Controversial conversations in gynecologic cancer – The ABCs of ADCs (antibody drug conjugates)
Abstract: The Society of Gynecologic Oncology (SGO) Journal Club is held quarterly to discuss topics related to gynecological malignancies. On November 8, 2022, the SGO Journal Club focused on antibody-drug conjugates (ADCs) in gynecologic malignancies, including the pharmacology, toxicities, and results of recent clinical trials leading to FDA approval of two new therapies for cervical and ovarian cancer. The invited discussants included Drs. Erin Hickey Zacholski, Roisin O'Cearbhaill, and Ursula Matulonis who discussed the pharmacology of ADCs, GOG-3023/ENGOT-cx6 (Coleman et al., 2021 May) and the SORAYA study (Ursula Matulonis, Domenica Lorusso, Ana Oaknin, Sandro Pignata, Hannelore Denys, Nicoletta Colombo, Toon Van Gorp, Jason Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Jiuzhou Wang, Elizabeth Noble, Brooke Esteves, Michael Method, Robert Coleman, Efficacy and Safety of Mirvetuximab Soravtansine in Patients with Platinum-Resistant Ovarian Cancer with High Folate Receptor Alpha Expression: Results from the SORAYA Study (LBA 4), Gynecologic Oncology, Volume 166, Supplement 1,, 2022). © 2023 The Author(s)
Keywords: adult; note; cancer immunotherapy; medical society; immunopharmacology; female genital tract cancer; human; female; mirvetuximab soravtansine; antibody drug conjugate; tisotumab vedotin
Journal Title: Gynecologic Oncology Reports
Volume: 45
ISSN: 2352-5789
Publisher: Elsevier B.V.  
Date Published: 2023-02-01
Start Page: 101141
Language: English
DOI: 10.1016/j.gore.2023.101141
PROVIDER: scopus
PMCID: PMC9931885
PUBMED: 36818197
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85147583162&doi=10.1016%2fj.gore.2023.101141&partnerID=40&md5=6d4f28efd077e82dd28bf64f3f3b8664
Notes: Note -- Export Date: 1 March 2023 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Roisin Eilish O'Cearbhaill
    271 O'Cearbhaill
Related MSK Work